JESSICA BLAIR: Open Payments
NPI 1881770378 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 22 payments from 8 companies in 2025. Trend: 2023 $391 · 2024 $481 · 2025 $625
Food & beverage: $625
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 13 | $443 |
| Baxter Healthcare | 1 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $31 |
| Novo Nordisk Inc | 1 | $24 |
| Amgen Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Boston Scientific Corporation | 1 | $14 |
Products named: AVEIR, JOT DX, Hillrom - Carnation Ambulatory Monitor, ESPRIT, LifeVest, Wegovy, CAMZYOS, ELIQUIS.
Industry payments across MS — which companies pay providers there.
